C07C 311/53
X and y not being nitrogen atoms
Official title: X and Y not being nitrogen atoms, e.g. N-sulfonylcarbamic acid
C07C311/53 (X and y not being nitrogen atoms) appears on 53 US grants and 57 published applications in this corpus.
Search patents in C07C- Granted patents
- 53
- Published applications
- 57
- Assignees
- 45
- Inventors
- 216
- Latest grant
- 24 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 3 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 3 | 0 |
| 2001 | 3 | 0 |
| 2002 | 1 | 1 |
| 2003 | 3 | 2 |
| 2004 | 0 | 2 |
| 2005 | 0 | 1 |
| 2006 | 2 | 5 |
| 2007 | 2 | 2 |
| 2008 | 1 | 5 |
| 2009 | 1 | 3 |
| 2010 | 1 | 2 |
| 2011 | 2 | 2 |
| 2012 | 2 | 3 |
| 2013 | 1 | 0 |
| 2014 | 1 | 1 |
| 2015 | 2 | 1 |
| 2016 | 2 | 1 |
| 2017 | 0 | 2 |
| 2018 | 1 | 2 |
| 2019 | 2 | 1 |
| 2020 | 1 | 1 |
| 2021 | 1 | 2 |
| 2022 | 0 | 1 |
| 2023 | 0 | 7 |
| 2024 | 2 | 4 |
| 2025 | 3 | 4 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Actinic ray-sensitive or radiation-sensitive resin composition, resist film, pattern forming method, method for manufacturing electronic device, and compound24 Mar 2026US 12,585,187 B2FUJIFILM Corporation
- Protoporphyrinogen oxidase inhibitors20 May 2025US 12,302,900 B2Enko Chem, Inc.
- Gamma-hydroxybutyrate delivering compounds and processes for making and using them18 Mar 2025US 12,251,445 B2Zevra Therapeutics, Inc.
- Compositions and methods for protein labeling, modification, analysis, and targeted delivery4 Feb 2025US 12,215,078 B2University of Massachusetts
- Hepatitis B antiviral agents6 Aug 2024US 12,054,493 B2Enanta Pharmaceuticals, Inc.
- Protoporphyrinogen oxidase inhibitors12 Mar 2026US 2026/0068883 A1Enko Chem, Inc.
- Compatibilizing agents and uses thereof22 Jan 2026US 2026/0022242 A1Lord Corporation
- Gamma-hydroxybutyrate delivering compounds and processes for making and using them4 Dec 2025US 2025/0367299 A1Zevra Therapeutics, Inc.
- Nonaqueous electrolyte solution, nonaqueous electrolyte solution battery, compound, and additive for nonaqueous electrolyte solution11 Sep 2025US 2025/0286113 A1Central Glass Company, Limited
- Gamma-hydroxybutyrate delivering compounds and processes for making and using them12 Jun 2025US 2025/0186591 A1Zevra Therapeutics, Inc.
Most cited
By later US patents
- Benzoyl-substituted phenylalanineamides74US 7,687,435 B2BASF SE · 2010
- N-acylsulfonamides, novel mixtures of herbicides and antidotes, and their use60US 6,235,680 B1Hoechst Schering AgrEvo GmbH · 2001
- Sulfonyl urea and carbamate ACAT inhibitors41US 5,981,595 AWarner-Lambert Company · 1999
- Ion channel modulators and methods of use27US 8,193,194 B2Vertex Pharmaceuticals Incorporated · 2012
- N-cyanoaryl-nitrogen heterocycles22US 5,593,945 ABayer Aktiengesellschaft · 1997